{"schema_version":"secwatch.filing_event.v1","accession":"0000012208-22-000080","form_type":"8-K","ticker":"BIO","cik":"0000012208","company_name":"BIO-RAD LABORATORIES, INC.","filed_at":"2022-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.874628+00:00","generated_at":"2026-06-22T02:58:05.090304+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Bio-Rad repurchases $67.1M of Class A shares QTD through Nov 8, 2022","bullets":["Remaining repurchase authorization: $231.0M as of Nov 8, 2022.","QTD repurchases: $67.1M at avg price $368.40/share (182,228 shares).","Previous remaining at Sept 30, 2022 was $298.1M.","Buybacks under program authorized by board in Nov 2017, Jul 2020, Jul 2022 for up to $650M total."],"urls":{"canonical":"https://secwatch.observer/filing/0000012208-22-000080","json":"https://secwatch.observer/filing/0000012208-22-000080.json","markdown":"https://secwatch.observer/filing/0000012208-22-000080.md","text":"https://secwatch.observer/filing/0000012208-22-000080.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/12208/000001220822000080/0000012208-22-000080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/12208/000001220822000080/bio-20221108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T02:58:05.090304+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}